A new Clinical Practice Guideline (CPG) for the diagnosis and treatment of acromegaly, a rare condition caused by excess growth hormone in the blood, has been issued. The Endocrine Society today ...

Acromegaly is a rare but serious hormonal disorder caused by excess growth hormone, usually due to a benign tumour in the pituitary gland. It typically develops in adulthood and leads to noticeable ...

Treatment of Acromegaly aims to reduce excess growth hormone, relieve the pressure that the tumour is exerting on the surrounding structures and thus improve symptoms of the disease. If not treated ...

Drugs for the rare hormone disorder acromegaly include older engineered peptides administered as frequent injections. A new FDA approval brings acromegaly patients the choice of a once-daily pill that ...

Gigantism and acromegaly are similar, but they also have notable differences. For starters, gigantism occurs in children. The overproduction of growth hormone occurs during puberty, when a child is ...